Association between embb mutations and ethambutol resistance in mycobacterium tuberculosis isolates from cuba and the dominican republic: Reproducible patterns and problems;Asociación entre las mutaciones en embB y la resistencia a etambutol en aislamientos de Mycobacterium tuberculosis de Cuba y República Dominicana: Patrones y problemas reproducibles

Revista Argentina de Microbiologia

Volumn 45, Issue 1, 2013, Pages 21-26

  Guerrero, Elba ^a   Lemus, Dihadenys ^b   Yzquierdo, Sergio ^b   Vílchez, Glenda ^a   Muñoz, Mariana ^a   Montoro, Ernesto ^b   Takiff, Howard ^a  

^a INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

^b INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

Author keywords

Drug sensitivity testing; embB mutations; Ethambutol resistance; Multidrug resistance; Mycobacterium tuberculosis

Indexed keywords

ARGININE; ASPARTIC ACID; CYSTEINE; ETHAMBUTOL; HISTIDINE; ISOLEUCINE; ISONIAZID; METHIONINE; RIFAMPICIN; STREPTOMYCIN; VALINE;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; CUBA; DOMINICAN REPUBLIC; DRUG SENSITIVITY; EMBB GENE; GENE; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; HUMAN; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POLYMERASE CHAIN REACTION;

EID: 84876070071     PISSN: 03257541     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Abadia E, Sequera M, Ortega D, Mendez MV, Escalona A, Da Mata O, Izarra E, Rojas Y, Jaspe R, Motiwala AS, Alland D, de Waard J, Takiff HE. Mycobacterium tuberculosis ecology in Venezuela: epidemiologic correlates of common spoligotypes and a large clonal cluster defined by MIRU-VNTR-24. BMC Infect Dis 2009; 9: 122.
2. Hazbon MH, Bobadilla del Valle M, Guerrero MI, Varma-Basil M, Filliol I, Cavatore M, Colangeli R, Safi H, Billman-Jacobe H, Lavender C, Fyfe J, Garcia-Garcia L, Davidow A, Brimacombe M, Leon CI, Porras T, Bose M, Chaves F, Eisenach KD, Sifuentes-Osornio J, Ponce de Leon A, Cave MD, Alland D. Role of embB codon 306 mutations in Mycobacterium tuberculosis revisited: a novel association with broad drug resistance and IS6110 clustering rather than ethambutol resistance. Antimicrob Agents Chemother 2005; 49: 3794-802.
3. Madison B, Robinson-Dunn B, George I, Gross W, Lipman H, Metchock B, Sloutsky A, Washabaugh G, Mazurek G, Ridderhof J. Multicenter evaluation of ethambutol susceptibility testing of Mycobacterium tuberculosis by agar proportion and radiometric methods. J Clin Microbiol 2002; 40: 3976-9.
4. Makarov V, Manina G, Mikusova K, Mollmann U, Ryabova O, Saint-Joanis B, Dhar N, Pasca MR, Buroni S, Lucarelli AP, Milano A, De Rossi E, Belanova M, Bobovska A, Dianiskova P, Kordulakova J, Sala C, Fullam E, Schneider P, McKinney JD, Brodin P, Christophe T, Waddell S, Butcher P, Albrethsen J, Rosenkrands I, Brosch R, Nandi V, Bharath S, Gaonkar S, Shandil RK, Balasubramanian V, Balganesh T, Tyagi S, Grosset J, Riccardi G, Cole ST. Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis. Science 2009; 324: 801-4.
5. Mokrousov I, Narvskaya O, Limeschenko E, Otten T, Vyshnevskiy B. Detection of ethambutol-resistant Mycobacterium tuberculosis strains by multiplex allelespecific PCR assay targeting embB306 mutations. J Clin Microbiol 2002; 40: 1617-20.
6. Perdigao J, Macedo R, Ribeiro A, Brum L, Portugal I. Genetic characterisation of the ethambutol resistancedetermining region in Mycobacterium tuberculosis: prevalence and significance of embB306 mutations. Int J Antimicrob Agents 2009; 33: 334-8.
7. Plinke C, Cox HS, Zarkua N, Karimovich HA, Braker K, Diel R, Rusch-Gerdes S, Feuerriegel S, Niemann S. embCAB sequence variation among ethambutolresistant Mycobacterium tuberculosis isolates without embB306 mutation. J Antimicrob Chemother 2010; 65: 1359-67.
8. Plinke C, Walter K, Aly S, Ehlers S, Niemann S. Mycobacterium tuberculosis embB codon 306 mutations confer moderately increased resistance to ethambutol in vitro and in vivo. Antimicrob Agents and Chemother 2011; 55: 2891-6.
9. Ramaswamy SV, Amin AG, Goksel S, Stager CE, Dou SJ, El Sahly H, Moghazeh SL, Kreiswirth BN, Musser JM. Molecular genetic analysis of nucleotide polymorphisms associated with ethambutol resistance in human isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother 2000; 44: 326-36.
10. Safi H, Fleischmann RD, Peterson SN, Jones MB, Jarrahi B, Alland D. Allelic exchange and mutant selection demonstrate that common clinical embCAB gene mutations only modestly increase resistance to ethambutol in Mycobacterium tuberculosis. Antimicrob Agents Chemother 2010; 54: 103-8.
11. Safi H, Sayers B, Hazbon MH, Alland D. Transfer of embB codon 306 mutations into clinical Mycobacterium tuberculosis strains alters susceptibility to ethambutol, isoniazid, and rifampin. Antimicrob Agents Chemother 2008; 52: 2027-34.
12. Shi D, Li L, Zhao Y, Jia Q, Li H, Coulter C, Jin Q, Zhu G. Characteristics of embB mutations in multidrugresistant Mycobacterium tuberculosis isolates in Henan, China. J Antimicrob Chemother 2011; 66: 2240-7.
13. Sreevatsan S, Stockbauer KE, Pan X, Kreiswirth BN, Moghazeh SL, Jacobs WR Jr., Telenti A, Musser JM. Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations. Antimicrob Agents Chemother 1997; 41: 1677-81.
14. Starks AM, Gumusboga A, Plikaytis BB, Shinnick TM, Posey JE. Mutations at embB codon 306 are an important molecular indicator of ethambutol resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 2009; 53: 1061-6.
15. Telenti A, Philipp WJ, Sreevatsan S, Bernasconi C, Stockbauer KE, Wieles B, Musser JM, Jacobs WR Jr. The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol. Nat Med 1997; 3: 567-70.